Recurrent High Risk Myelodysplastic Syndrome Recruiting Phase 1 Trials for Hydrocortisone cypionate (DB14541)

IndicationStatusPhase
DBCOND0092721 (Recurrent High Risk Myelodysplastic Syndrome)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03813147Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic SyndromeTreatment